Clinical2Digital
↗San Diego, USA
Clinical2Digital (C2D) is a specialized consultancy and technology provider focusing on the intersection of clinical research, precision medicine, and digital innovation. The company provides strategic advisory services to biopharma and diagnostic firms, helping them navigate the complexities of biomarker integration, companion diagnostic (CDx) development, and regulatory filings (IND/NDA/BLA).
Beyond consulting, C2D develops proprietary digital tools designed to optimize clinical trial operations. Their flagship products include C*STAR, an enterprise-grade specimen tracking and reporting system, and SPAIx, an AI-driven platform for literature analysis. The firm leverages over 30 years of collective experience from top-tier pharmaceutical companies to streamline the path from clinical data to digital insights.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Precision Medicine Consulting
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Bootstrapped/Seed
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Biomarkers, Companion Diagnostics, Omics, Big Data
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Stanford Medical Center (Academic Collaboration), Top 10 Clinical Trial CROs (Strategic Partnerships)
COMPETITION
Position:Niche Player
Competitors:Precision for Medicine, IQVIA (Consulting), ZS Associates, Halloran Consulting Group, Veeva Systems
LEADERSHIP
Key Executives:
Chetan Deshpande - Founder & Principal Consultant
Scientific Founders:Chetan Deshpande
LINKS
Website:clinical2digital.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clinical2Digital. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.